Table 1.
Patients’ characteristics
| Male | Female | Total | P -value | |
|---|---|---|---|---|
|
N (%) |
102 (61.00) |
66 (39.00) |
168 (100.00) |
|
|
Age (years) |
52.91 ± 13.65 |
50.15 ± 14.56 |
51.83 ± 14.03 |
0.06 |
|
Primary tumor site |
|
|
|
|
| Gastrointestinal tract |
93 (55.36) |
52 (30.95) |
145 (86.31) |
0.02* |
| Stomach |
12 (7.14) |
4 (2.38) |
16 (9.52) |
0.22 |
| Duodenum |
6 (3.57) |
3 (1.79) |
9 (5.36) |
1.00 |
| Jejunum |
1 (0.60) |
0(0.0) |
1 (0.60) |
1.00 |
| Ileum |
3 (1.79) |
1 (0.60) |
4 (2.38) |
1.00 |
| Colon |
6 (3.57) |
2 (1.19) |
8 (4.76) |
0.48 |
| Appendix |
4 (2.38) |
4 (2.38) |
8 (4.76) |
0.71 |
| Rectum |
61 (36.31) |
38 (22.62) |
99 (58.93) |
0.74 |
| Pancreas |
9 (5.36) |
14 (8.33) |
23 (13.69) |
0.02* |
|
Clinical Symptoms |
|
|
|
|
| Abdominal or back pain |
27 (16.07) |
22 (13.10) |
49 (29.17) |
0.33 |
| Gastrointestinal bleedinga |
28 (16.67) |
15 (8.93) |
43 (25.60) |
0.49 |
| Dyspepsiab |
16 (9.52) |
8 (4.76) |
24 (14.29) |
0.52 |
| Diarrhea |
18 (10.71) |
3 (1.79) |
21 (12.50) |
0.12 |
| Tenesmus |
13 (7.74) |
6 (3.57) |
19 (11.31) |
0.47 |
| Appetite loss |
11 (6.55) |
7 (4.17) |
18 (10.71) |
0.97 |
| Constipation |
3 (1.79) |
5 (2.98) |
8 (4.76) |
0.27 |
| Hypoglycemiac |
5 (2.98) |
2 (1.19) |
7 (4.17) |
0.71 |
| Weight loss |
4 (2.38) |
1 (0.60) |
5 (2.98) |
0.65 |
| Asthenia |
1 (0.60) |
1 (0.60) |
2 (1.19) |
1.00 |
| Dysphagia |
1 (0.60) |
0(0) |
1 (0.60) |
1.00 |
|
Main Signs |
|
|
|
|
| Abdominal mass |
2 (1.19) |
2 (1.19) |
4 (2.38) |
0.65 |
| Jaundiced |
1 (0.60) |
1 (0.60) |
2 (1.19) |
1.00 |
| Rash | 1 (0.60) | 2 (1.19) | 3 (1.79) | 0.56 |
afecal occult blood, bloody stool, hematemesis.
bfullness, bloating, belching, nausea, vomiting.
ctremors, cold sweats, palpitations, hunger, irritability, headache, dizziness, blurred vision, disorientation, coma or seizures.
dskin or sclera.